Trial Profile
STAMPOUT: Study of Antibody for Methamphetamine Outpatient Therapy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Mar 2022
Price :
$35
*
At a glance
- Drugs IXT-m200 (Primary)
- Indications Substance-related disorders
- Focus Pharmacokinetics; Proof of concept
- Acronyms STAMPOUT
- Sponsors InterveXion Therapeutics
- 23 Aug 2021 Status changed from active, no longer recruiting to completed.
- 03 May 2021 Planned End Date changed from 1 Mar 2021 to 1 Jun 2021.
- 03 May 2021 Status changed from completed to active, no longer recruiting.